Status:
COMPLETED
Study Evaluating Management of Patients With Moderate and Severe Psoriasis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or syste...
Eligibility Criteria
Inclusion
- Main
- ·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office.
- Main
Exclusion
- ·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
469 Patients enrolled
Trial Details
Trial ID
NCT00894777
Start Date
March 1 2009
End Date
November 1 2009
Last Update
November 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madrid, Madrid, Spain, 28031